Direct Utilization of Plasma Proteins for the In Vivo Assembly of Protein-Drug/ …

Abstract

The present invention includes compositions and methods for making and using a drug conjugated to a peptide or protein that binds specifically to a ligand in vivo, wherein the conjugate binds to its ligand in vivo and increases the half-life of the drug.